White Papers
Discover Why Douglas Softgels Are the Smarter Choice for Oral Drug Formulation
From improved stability and shelf-life to enhanced patient compliance, softgel technology is redefining oral medicines.
How to optimize your results and overcome specificity challenges in gene expression analysis
Real-time PCR for gene expression analysis is commonly used to quantify gene-specific RNA transcripts expressed by cells or viruses. However, gene expression analysis presents unique challenges, as experimental results often do not follow predictable patterns, and reliable positive controls are not always available.
New modalities, new tools Choosing a flexible digital platform for drug discovery
As pharmaceutical innovation rapidly evolves, the complexity of data generated from RNA therapeutics, gene therapies, antibody-drug conjugates (ADCs), and protein degraders necessitates a new approach to digital infrastructure.
Enhancing the efficiency of CAR T cell therapy manufacturing through automated bioprocessing
This white paper describes the significance of Cellmation Software in automating and integrating the CAR-T cell manufacturing workflow. Modular instruments enhance flexibility and scalability in cell therapy manufacturing. However, automated control of the processes is critical in reducing manual touchpoints and ensures efficiency and safety.
From Protacs to Dacs : How targeted protein degraders are breaking rules and boundaries in drug design
Advancements in healthcare diagnostics, emphasizing the need for innovative technologies to improve disease detection and patient outcomes.
Protect Your Pharma Supply Chain from Global Disruptions
In today’s unpredictable world, pharmaceutical supply chains face growing risks—from geopolitical tensions and regulatory shifts to raw material shortages and natural disasters.
Discover why Electronic Batch Record Management is the smarter alternative to traditional MES
Pharmaceutical manufacturers are under increasing pressure to ensure compliance, minimize errors, and accelerate batch release.
Revolutionize Biomanufacturing with Advanced Process Liquid Outsourcing
In the dynamic world of biopharmaceuticals, the demand for innovative and efficient manufacturing processes is higher than ever. Contract Development and Manufacturing Organizations (CDMOs) are increasingly turning to outsourcing Process Liquid Buffers (PLBs) to enhance scalability, quality, and flexibility.
Automating Octet® Assays for Ligand Screening
Drug development and production is challenging. Avitide, based in Lebanon, New Hampshire, provides on-demand development and supply of high-performance affinity purification resins for the manufacture of biotherapeutic drug molecules.
Buffers in Biomanufacturing
The complexity and criticality of buffer preparation have grown of late for several reasons. Advances in product offerings, bioprocessing materials, process technologies and facility design have increased the number of factors to be considered
